7th February - Mirena: The Next Chapter
Bayer is delighted to announce the licence extension to Mirena® in contraception which now is 8 years and the symptom-led extension in idiopathic Heavy Menstrual Bleeding (HMB) for up to 8 years should symptoms not return after 5 years of use.1
Dr Diana Mansour
Consultant in Community Gynaecology and Reproductive Healthcare
Dr Paula Briggs
Consultant in Sexual and Reproductive Health
1. Mirena SmPC 2024
Endometrial protection indication has not changed from 4 years.